1h Free Analyst Time
The global tamiflu oseltamivir phosphate market is forecasted to grow by USD 204.5 million during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the global tamiflu oseltamivir phosphate market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by seasonal influenza incidence and severity, government stockpiling and pandemic preparedness policies, widespread availability and affordability of generic formulations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global tamiflu oseltamivir phosphate market is segmented as below:
By Type
- Branded
- Generic
By Formulation
- Capsules
- Suspension
By Indication
- Influenza A
- Influenza B
- Swine flu
By Region
- Asia
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- The Netherlands
- Rest of World (RoW)
The report on the global tamiflu oseltamivir phosphate market covers the following areas:
- Global tamiflu oseltamivir phosphate market sizing
- Global tamiflu oseltamivir phosphate market forecast
- Global tamiflu oseltamivir phosphate market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Formulation
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2024-2029
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Tamiflu Oseltamivir Phosphate Market 2019 - 2023
- Historic Market Size - Data Table on Global Tamiflu Oseltamivir Phosphate Market 2019 - 2023 ($ million)
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- Historic Market Size - Formulation Segment 2019 - 2023 ($ million)
- Historic Market Size - Indication Segment 2019 - 2023 ($ million)
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on global tamiflu oseltamivir phosphate market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- Threat of new entrants - Impact of key factors in 2024 and 2029
- Threat of substitutes - Impact of key factors in 2024 and 2029
- Threat of rivalry - Impact of key factors in 2024 and 2029
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- Chart on Comparison by Type
- Data Table on Comparison by Type
- Chart on Branded - Market size and forecast 2024-2029 ($ million)
- Data Table on Branded - Market size and forecast 2024-2029 ($ million)
- Chart on Branded - Year-over-year growth 2024-2029 (%)
- Data Table on Branded - Year-over-year growth 2024-2029 (%)
- Chart on Generic - Market size and forecast 2024-2029 ($ million)
- Data Table on Generic - Market size and forecast 2024-2029 ($ million)
- Chart on Generic - Year-over-year growth 2024-2029 (%)
- Data Table on Generic - Year-over-year growth 2024-2029 (%)
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Formulation
9.1 Market segments
- Chart on Formulation - Market share 2024-2029 (%)
- Data Table on Formulation - Market share 2024-2029 (%)
- Chart on Comparison by Formulation
- Data Table on Comparison by Formulation
- Chart on Capsules - Market size and forecast 2024-2029 ($ million)
- Data Table on Capsules - Market size and forecast 2024-2029 ($ million)
- Chart on Capsules - Year-over-year growth 2024-2029 (%)
- Data Table on Capsules - Year-over-year growth 2024-2029 (%)
- Chart on Suspension - Market size and forecast 2024-2029 ($ million)
- Data Table on Suspension - Market size and forecast 2024-2029 ($ million)
- Chart on Suspension - Year-over-year growth 2024-2029 (%)
- Data Table on Suspension - Year-over-year growth 2024-2029 (%)
- Market opportunity by Formulation ($ million)
- Data Table on Market opportunity by Formulation ($ million)
10 Market Segmentation by Indication
10.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
- Chart on Influenza A - Market size and forecast 2024-2029 ($ million)
- Data Table on Influenza A - Market size and forecast 2024-2029 ($ million)
- Chart on Influenza A - Year-over-year growth 2024-2029 (%)
- Data Table on Influenza A - Year-over-year growth 2024-2029 (%)
- Chart on Influenza B - Market size and forecast 2024-2029 ($ million)
- Data Table on Influenza B - Market size and forecast 2024-2029 ($ million)
- Chart on Influenza B - Year-over-year growth 2024-2029 (%)
- Data Table on Influenza B - Year-over-year growth 2024-2029 (%)
- Chart on Swine flu - Market size and forecast 2024-2029 ($ million)
- Data Table on Swine flu - Market size and forecast 2024-2029 ($ million)
- Chart on Swine flu - Year-over-year growth 2024-2029 (%)
- Data Table on Swine flu - Year-over-year growth 2024-2029 (%)
- Market opportunity by Indication ($ million)
- Data Table on Market opportunity by Indication ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- Chart on Singapore - Market size and forecast 2024-2029 ($ million)
- Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
- Chart on Singapore - Year-over-year growth 2024-2029 (%)
- Data Table on Singapore - Year-over-year growth 2024-2029 (%)
- Chart on Thailand - Market size and forecast 2024-2029 ($ million)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Chart on Spain - Market size and forecast 2024-2029 ($ million)
- Data Table on Spain - Market size and forecast 2024-2029 ($ million)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- Chart on Russia - Market size and forecast 2024-2029 ($ million)
- Data Table on Russia - Market size and forecast 2024-2029 ($ million)
- Chart on Russia - Year-over-year growth 2024-2029 (%)
- Data Table on Russia - Year-over-year growth 2024-2029 (%)
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- Chart on South Africa - Market size and forecast 2024-2029 ($ million)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- Chart on Australia - Market size and forecast 2024-2029 ($ million)
- Data Table on Australia - Market size and forecast 2024-2029 ($ million)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- Chart on Turkey - Market size and forecast 2024-2029 ($ million)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Seasonal influenza incidence and severity
- Government stockpiling and pandemic preparedness policies
- Widespread availability and affordability of generic formulations
- Intense generic competition and severe price erosion
- High threat from substitute products and preventative measures
- Demand volatility and complex supply chain management
- Impact of drivers and challenges in 2024 and 2029
- Increasing adoption of novel antiviral therapies
- Strategic diversification of manufacturing footprints
- Integration of digital health and advanced diagnostics in clinical pathways
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- Alembic Pharmaceuticals Ltd. - Overview
- Alembic Pharmaceuticals Ltd. - Product / Service
- Alembic Pharmaceuticals Ltd. - Key offerings
- SWOT
- Amneal Pharmaceuticals Inc. - Overview
- Amneal Pharmaceuticals Inc. - Business segments
- Amneal Pharmaceuticals Inc. - Key news
- Amneal Pharmaceuticals Inc. - Key offerings
- Amneal Pharmaceuticals Inc. - Segment focus
- SWOT
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
- Cipla Inc. - Overview
- Cipla Inc. - Business segments
- Cipla Inc. - Key news
- Cipla Inc. - Key offerings
- Cipla Inc. - Segment focus
- SWOT
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT
- Laurus Labs Ltd. - Overview
- Laurus Labs Ltd. - Product / Service
- Laurus Labs Ltd. - Key offerings
- SWOT
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
- Macleods Pharmaceuticals Ltd. - Overview
- Macleods Pharmaceuticals Ltd. - Product / Service
- Macleods Pharmaceuticals Ltd. - Key offerings
- SWOT
- MSN Laboratories - Overview
- MSN Laboratories - Product / Service
- MSN Laboratories - Key offerings
- SWOT
- NATCO Pharma Ltd. - Overview
- NATCO Pharma Ltd. - Product / Service
- NATCO Pharma Ltd. - Key offerings
- SWOT
- Strides Pharma Ltd. - Overview
- Strides Pharma Ltd. - Product / Service
- Strides Pharma Ltd. - Key offerings
- SWOT
- Teva Pharmaceutical Ltd. - Overview
- Teva Pharmaceutical Ltd. - Business segments
- Teva Pharmaceutical Ltd. - Key news
- Teva Pharmaceutical Ltd. - Key offerings
- Teva Pharmaceutical Ltd. - Segment focus
- SWOT
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
- Zydus Group - Overview
- Zydus Group - Product / Service
- Zydus Group - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Formulation
Exhibit 7: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Tamiflu Oseltamivir Phosphate Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - Formulation Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Indication Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Type - Market share 2024-2029 (%)
Exhibit 39: Data Table on Type - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Branded - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Branded - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Branded - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Branded - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Generic - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Generic - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Generic - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Generic - Year-over-year growth 2024-2029 (%)
Exhibit 50: Market opportunity by Type ($ million)
Exhibit 51: Data Table on Market opportunity by Type ($ million)
Exhibit 52: Chart on Formulation - Market share 2024-2029 (%)
Exhibit 53: Data Table on Formulation - Market share 2024-2029 (%)
Exhibit 54: Chart on Comparison by Formulation
Exhibit 55: Data Table on Comparison by Formulation
Exhibit 56: Chart on Capsules - Market size and forecast 2024-2029 ($ million)
Exhibit 57: Data Table on Capsules - Market size and forecast 2024-2029 ($ million)
Exhibit 58: Chart on Capsules - Year-over-year growth 2024-2029 (%)
Exhibit 59: Data Table on Capsules - Year-over-year growth 2024-2029 (%)
Exhibit 60: Chart on Suspension - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Suspension - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Suspension - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Suspension - Year-over-year growth 2024-2029 (%)
Exhibit 64: Market opportunity by Formulation ($ million)
Exhibit 65: Data Table on Market opportunity by Formulation ($ million)
Exhibit 66: Chart on Indication - Market share 2024-2029 (%)
Exhibit 67: Data Table on Indication - Market share 2024-2029 (%)
Exhibit 68: Chart on Comparison by Indication
Exhibit 69: Data Table on Comparison by Indication
Exhibit 70: Chart on Influenza A - Market size and forecast 2024-2029 ($ million)
Exhibit 71: Data Table on Influenza A - Market size and forecast 2024-2029 ($ million)
Exhibit 72: Chart on Influenza A - Year-over-year growth 2024-2029 (%)
Exhibit 73: Data Table on Influenza A - Year-over-year growth 2024-2029 (%)
Exhibit 74: Chart on Influenza B - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Influenza B - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Influenza B - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Influenza B - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Swine flu - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Swine flu - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Swine flu - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Swine flu - Year-over-year growth 2024-2029 (%)
Exhibit 82: Market opportunity by Indication ($ million)
Exhibit 83: Data Table on Market opportunity by Indication ($ million)
Exhibit 84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 85: Chart on Market share by geography 2024-2029 (%)
Exhibit 86: Data Table on Market share by geography 2024-2029 (%)
Exhibit 87: Chart on Geographic comparison
Exhibit 88: Data Table on Geographic comparison
Exhibit 89: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 90: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 91: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 92: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 93: Chart on Regional Comparison - Asia
Exhibit 94: Data Table on Regional Comparison - Asia
Exhibit 95: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 99: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 103: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 116: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 117: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 118: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 119: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 120: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 121: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 122: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 123: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 124: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 125: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 126: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 127: Chart on Regional Comparison - North America
Exhibit 128: Data Table on Regional Comparison - North America
Exhibit 129: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Regional Comparison - Europe
Exhibit 146: Data Table on Regional Comparison - Europe
Exhibit 147: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 148: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 149: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 150: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 151: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 152: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 153: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 154: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 155: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 182: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 183: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 185: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 186: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 187: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 188: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 205: Market opportunity by geography ($ million)
Exhibit 206: Data Tables on Market opportunity by geography ($ million)
Exhibit 207: Impact of drivers and challenges in 2024 and 2029
Exhibit 208: Overview on criticality of inputs and factors of differentiation
Exhibit 209: Overview on factors of disruption
Exhibit 210: Impact of key risks on business
Exhibit 211: Companies covered
Exhibit 212: Company ranking index
Exhibit 213: Matrix on companies position and classification
Exhibit 214: Alembic Pharmaceuticals Ltd. - Overview
Exhibit 215: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibit 216: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibit 217: SWOT
Exhibit 218: Amneal Pharmaceuticals Inc. - Overview
Exhibit 219: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 220: Amneal Pharmaceuticals Inc. - Key news
Exhibit 221: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 222: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 223: SWOT
Exhibit 224: Aurobindo Pharma Ltd. - Overview
Exhibit 225: Aurobindo Pharma Ltd. - Product / Service
Exhibit 226: Aurobindo Pharma Ltd. - Key offerings
Exhibit 227: SWOT
Exhibit 228: Cipla Inc. - Overview
Exhibit 229: Cipla Inc. - Business segments
Exhibit 230: Cipla Inc. - Key news
Exhibit 231: Cipla Inc. - Key offerings
Exhibit 232: Cipla Inc. - Segment focus
Exhibit 233: SWOT
Exhibit 234: F. Hoffmann La Roche Ltd. - Overview
Exhibit 235: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 236: F. Hoffmann La Roche Ltd. - Key news
Exhibit 237: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 238: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 239: SWOT
Exhibit 240: Gilead Sciences Inc. - Overview
Exhibit 241: Gilead Sciences Inc. - Product / Service
Exhibit 242: Gilead Sciences Inc. - Key news
Exhibit 243: Gilead Sciences Inc. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Laurus Labs Ltd. - Overview
Exhibit 246: Laurus Labs Ltd. - Product / Service
Exhibit 247: Laurus Labs Ltd. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Lupin Ltd. - Overview
Exhibit 250: Lupin Ltd. - Business segments
Exhibit 251: Lupin Ltd. - Key news
Exhibit 252: Lupin Ltd. - Key offerings
Exhibit 253: Lupin Ltd. - Segment focus
Exhibit 254: SWOT
Exhibit 255: Macleods Pharmaceuticals Ltd. - Overview
Exhibit 256: Macleods Pharmaceuticals Ltd. - Product / Service
Exhibit 257: Macleods Pharmaceuticals Ltd. - Key offerings
Exhibit 258: SWOT
Exhibit 259: MSN Laboratories - Overview
Exhibit 260: MSN Laboratories - Product / Service
Exhibit 261: MSN Laboratories - Key offerings
Exhibit 262: SWOT
Exhibit 263: NATCO Pharma Ltd. - Overview
Exhibit 264: NATCO Pharma Ltd. - Product / Service
Exhibit 265: NATCO Pharma Ltd. - Key offerings
Exhibit 266: SWOT
Exhibit 267: Strides Pharma Ltd. - Overview
Exhibit 268: Strides Pharma Ltd. - Product / Service
Exhibit 269: Strides Pharma Ltd. - Key offerings
Exhibit 270: SWOT
Exhibit 271: Teva Pharmaceutical Ltd. - Overview
Exhibit 272: Teva Pharmaceutical Ltd. - Business segments
Exhibit 273: Teva Pharmaceutical Ltd. - Key news
Exhibit 274: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 275: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 276: SWOT
Exhibit 277: Viatris Inc. - Overview
Exhibit 278: Viatris Inc. - Business segments
Exhibit 279: Viatris Inc. - Key news
Exhibit 280: Viatris Inc. - Key offerings
Exhibit 281: Viatris Inc. - Segment focus
Exhibit 282: SWOT
Exhibit 283: Zydus Group - Overview
Exhibit 284: Zydus Group - Product / Service
Exhibit 285: Zydus Group - Key offerings
Exhibit 286: SWOT
Exhibit 287: Inclusions checklist
Exhibit 288: Exclusions checklist
Exhibit 289: Currency conversion rates for US$
Exhibit 290: Research methodology
Exhibit 291: Information sources
Exhibit 292: Data validation
Exhibit 293: Validation techniques employed for market sizing
Exhibit 294: Data synthesis
Exhibit 295: 360 degree market analysis
Exhibit 296: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Formulation
Exhibit 7: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2024 and 2029
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibit 25: Historic Market Size - Data Table on Global Tamiflu Oseltamivir Phosphate Market 2019 - 2023 ($ million)
Exhibit 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibit 27: Historic Market Size - Formulation Segment 2019 - 2023 ($ million)
Exhibit 28: Historic Market Size - Indication Segment 2019 - 2023 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2024 and 2029
Exhibit 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibit 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibit 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibit 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibit 37: Chart on Market condition - Five forces 2024 and 2029
Exhibit 38: Chart on Type - Market share 2024-2029 (%)
Exhibit 39: Data Table on Type - Market share 2024-2029 (%)
Exhibit 40: Chart on Comparison by Type
Exhibit 41: Data Table on Comparison by Type
Exhibit 42: Chart on Branded - Market size and forecast 2024-2029 ($ million)
Exhibit 43: Data Table on Branded - Market size and forecast 2024-2029 ($ million)
Exhibit 44: Chart on Branded - Year-over-year growth 2024-2029 (%)
Exhibit 45: Data Table on Branded - Year-over-year growth 2024-2029 (%)
Exhibit 46: Chart on Generic - Market size and forecast 2024-2029 ($ million)
Exhibit 47: Data Table on Generic - Market size and forecast 2024-2029 ($ million)
Exhibit 48: Chart on Generic - Year-over-year growth 2024-2029 (%)
Exhibit 49: Data Table on Generic - Year-over-year growth 2024-2029 (%)
Exhibit 50: Market opportunity by Type ($ million)
Exhibit 51: Data Table on Market opportunity by Type ($ million)
Exhibit 52: Chart on Formulation - Market share 2024-2029 (%)
Exhibit 53: Data Table on Formulation - Market share 2024-2029 (%)
Exhibit 54: Chart on Comparison by Formulation
Exhibit 55: Data Table on Comparison by Formulation
Exhibit 56: Chart on Capsules - Market size and forecast 2024-2029 ($ million)
Exhibit 57: Data Table on Capsules - Market size and forecast 2024-2029 ($ million)
Exhibit 58: Chart on Capsules - Year-over-year growth 2024-2029 (%)
Exhibit 59: Data Table on Capsules - Year-over-year growth 2024-2029 (%)
Exhibit 60: Chart on Suspension - Market size and forecast 2024-2029 ($ million)
Exhibit 61: Data Table on Suspension - Market size and forecast 2024-2029 ($ million)
Exhibit 62: Chart on Suspension - Year-over-year growth 2024-2029 (%)
Exhibit 63: Data Table on Suspension - Year-over-year growth 2024-2029 (%)
Exhibit 64: Market opportunity by Formulation ($ million)
Exhibit 65: Data Table on Market opportunity by Formulation ($ million)
Exhibit 66: Chart on Indication - Market share 2024-2029 (%)
Exhibit 67: Data Table on Indication - Market share 2024-2029 (%)
Exhibit 68: Chart on Comparison by Indication
Exhibit 69: Data Table on Comparison by Indication
Exhibit 70: Chart on Influenza A - Market size and forecast 2024-2029 ($ million)
Exhibit 71: Data Table on Influenza A - Market size and forecast 2024-2029 ($ million)
Exhibit 72: Chart on Influenza A - Year-over-year growth 2024-2029 (%)
Exhibit 73: Data Table on Influenza A - Year-over-year growth 2024-2029 (%)
Exhibit 74: Chart on Influenza B - Market size and forecast 2024-2029 ($ million)
Exhibit 75: Data Table on Influenza B - Market size and forecast 2024-2029 ($ million)
Exhibit 76: Chart on Influenza B - Year-over-year growth 2024-2029 (%)
Exhibit 77: Data Table on Influenza B - Year-over-year growth 2024-2029 (%)
Exhibit 78: Chart on Swine flu - Market size and forecast 2024-2029 ($ million)
Exhibit 79: Data Table on Swine flu - Market size and forecast 2024-2029 ($ million)
Exhibit 80: Chart on Swine flu - Year-over-year growth 2024-2029 (%)
Exhibit 81: Data Table on Swine flu - Year-over-year growth 2024-2029 (%)
Exhibit 82: Market opportunity by Indication ($ million)
Exhibit 83: Data Table on Market opportunity by Indication ($ million)
Exhibit 84: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 85: Chart on Market share by geography 2024-2029 (%)
Exhibit 86: Data Table on Market share by geography 2024-2029 (%)
Exhibit 87: Chart on Geographic comparison
Exhibit 88: Data Table on Geographic comparison
Exhibit 89: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 90: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibit 91: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 92: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibit 93: Chart on Regional Comparison - Asia
Exhibit 94: Data Table on Regional Comparison - Asia
Exhibit 95: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibit 99: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibit 103: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibit 104: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibit 105: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibit 106: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibit 107: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 108: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibit 109: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 110: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibit 111: Chart on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 112: Data Table on Indonesia - Market size and forecast 2024-2029 ($ million)
Exhibit 113: Chart on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 114: Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
Exhibit 115: Chart on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 116: Data Table on Singapore - Market size and forecast 2024-2029 ($ million)
Exhibit 117: Chart on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 118: Data Table on Singapore - Year-over-year growth 2024-2029 (%)
Exhibit 119: Chart on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 120: Data Table on Thailand - Market size and forecast 2024-2029 ($ million)
Exhibit 121: Chart on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 122: Data Table on Thailand - Year-over-year growth 2024-2029 (%)
Exhibit 123: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 124: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibit 125: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibit 126: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibit 127: Chart on Regional Comparison - North America
Exhibit 128: Data Table on Regional Comparison - North America
Exhibit 129: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibit 130: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibit 131: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibit 132: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibit 133: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 134: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibit 135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibit 137: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 138: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
Exhibit 139: Chart on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 140: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
Exhibit 141: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 142: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibit 143: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 144: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibit 145: Chart on Regional Comparison - Europe
Exhibit 146: Data Table on Regional Comparison - Europe
Exhibit 147: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 148: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibit 149: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 150: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibit 151: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibit 152: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibit 153: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibit 154: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibit 155: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 156: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibit 157: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibit 158: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibit 159: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 160: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibit 161: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 162: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibit 163: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 164: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibit 165: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 166: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibit 167: Chart on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 168: Data Table on Russia - Market size and forecast 2024-2029 ($ million)
Exhibit 169: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 170: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibit 171: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 172: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
Exhibit 173: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 174: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
Exhibit 175: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 176: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibit 177: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 178: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibit 179: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 180: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 181: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 182: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibit 183: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 184: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibit 185: Chart on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 186: Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
Exhibit 187: Chart on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 188: Data Table on South Africa - Year-over-year growth 2024-2029 (%)
Exhibit 189: Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 190: Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ million)
Exhibit 191: Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 192: Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
Exhibit 193: Chart on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 194: Data Table on UAE - Market size and forecast 2024-2029 ($ million)
Exhibit 195: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 196: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibit 197: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 198: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibit 199: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 200: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibit 201: Chart on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 202: Data Table on Turkey - Market size and forecast 2024-2029 ($ million)
Exhibit 203: Chart on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 204: Data Table on Turkey - Year-over-year growth 2024-2029 (%)
Exhibit 205: Market opportunity by geography ($ million)
Exhibit 206: Data Tables on Market opportunity by geography ($ million)
Exhibit 207: Impact of drivers and challenges in 2024 and 2029
Exhibit 208: Overview on criticality of inputs and factors of differentiation
Exhibit 209: Overview on factors of disruption
Exhibit 210: Impact of key risks on business
Exhibit 211: Companies covered
Exhibit 212: Company ranking index
Exhibit 213: Matrix on companies position and classification
Exhibit 214: Alembic Pharmaceuticals Ltd. - Overview
Exhibit 215: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibit 216: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibit 217: SWOT
Exhibit 218: Amneal Pharmaceuticals Inc. - Overview
Exhibit 219: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 220: Amneal Pharmaceuticals Inc. - Key news
Exhibit 221: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 222: Amneal Pharmaceuticals Inc. - Segment focus
Exhibit 223: SWOT
Exhibit 224: Aurobindo Pharma Ltd. - Overview
Exhibit 225: Aurobindo Pharma Ltd. - Product / Service
Exhibit 226: Aurobindo Pharma Ltd. - Key offerings
Exhibit 227: SWOT
Exhibit 228: Cipla Inc. - Overview
Exhibit 229: Cipla Inc. - Business segments
Exhibit 230: Cipla Inc. - Key news
Exhibit 231: Cipla Inc. - Key offerings
Exhibit 232: Cipla Inc. - Segment focus
Exhibit 233: SWOT
Exhibit 234: F. Hoffmann La Roche Ltd. - Overview
Exhibit 235: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 236: F. Hoffmann La Roche Ltd. - Key news
Exhibit 237: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 238: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 239: SWOT
Exhibit 240: Gilead Sciences Inc. - Overview
Exhibit 241: Gilead Sciences Inc. - Product / Service
Exhibit 242: Gilead Sciences Inc. - Key news
Exhibit 243: Gilead Sciences Inc. - Key offerings
Exhibit 244: SWOT
Exhibit 245: Laurus Labs Ltd. - Overview
Exhibit 246: Laurus Labs Ltd. - Product / Service
Exhibit 247: Laurus Labs Ltd. - Key offerings
Exhibit 248: SWOT
Exhibit 249: Lupin Ltd. - Overview
Exhibit 250: Lupin Ltd. - Business segments
Exhibit 251: Lupin Ltd. - Key news
Exhibit 252: Lupin Ltd. - Key offerings
Exhibit 253: Lupin Ltd. - Segment focus
Exhibit 254: SWOT
Exhibit 255: Macleods Pharmaceuticals Ltd. - Overview
Exhibit 256: Macleods Pharmaceuticals Ltd. - Product / Service
Exhibit 257: Macleods Pharmaceuticals Ltd. - Key offerings
Exhibit 258: SWOT
Exhibit 259: MSN Laboratories - Overview
Exhibit 260: MSN Laboratories - Product / Service
Exhibit 261: MSN Laboratories - Key offerings
Exhibit 262: SWOT
Exhibit 263: NATCO Pharma Ltd. - Overview
Exhibit 264: NATCO Pharma Ltd. - Product / Service
Exhibit 265: NATCO Pharma Ltd. - Key offerings
Exhibit 266: SWOT
Exhibit 267: Strides Pharma Ltd. - Overview
Exhibit 268: Strides Pharma Ltd. - Product / Service
Exhibit 269: Strides Pharma Ltd. - Key offerings
Exhibit 270: SWOT
Exhibit 271: Teva Pharmaceutical Ltd. - Overview
Exhibit 272: Teva Pharmaceutical Ltd. - Business segments
Exhibit 273: Teva Pharmaceutical Ltd. - Key news
Exhibit 274: Teva Pharmaceutical Ltd. - Key offerings
Exhibit 275: Teva Pharmaceutical Ltd. - Segment focus
Exhibit 276: SWOT
Exhibit 277: Viatris Inc. - Overview
Exhibit 278: Viatris Inc. - Business segments
Exhibit 279: Viatris Inc. - Key news
Exhibit 280: Viatris Inc. - Key offerings
Exhibit 281: Viatris Inc. - Segment focus
Exhibit 282: SWOT
Exhibit 283: Zydus Group - Overview
Exhibit 284: Zydus Group - Product / Service
Exhibit 285: Zydus Group - Key offerings
Exhibit 286: SWOT
Exhibit 287: Inclusions checklist
Exhibit 288: Exclusions checklist
Exhibit 289: Currency conversion rates for US$
Exhibit 290: Research methodology
Exhibit 291: Information sources
Exhibit 292: Data validation
Exhibit 293: Validation techniques employed for market sizing
Exhibit 294: Data synthesis
Exhibit 295: 360 degree market analysis
Exhibit 296: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global tamiflu oseltamivir phosphate market: Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Cipla Inc., Epic Pharma LLC, F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Hetero Labs Ltd., Jubilant Generics Ltd., Laurus Labs Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., MSN Laboratories, NATCO Pharma Ltd., Nivagen Pharmaceuticals Inc., Strides Pharma Ltd., Teva Pharmaceutical Ltd., Viatris Inc., Zydus Group.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing adoption of novel antiviral therapies."
According to the report, one of the major drivers for this market is the seasonal influenza incidence and severity.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alembic Pharmaceuticals Ltd.
- Amneal Pharmaceuticals Inc.
- Aurobindo Pharma Ltd.
- Cipla Inc.
- Epic Pharma LLC
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- Hetero Labs Ltd.
- Jubilant Generics Ltd.
- Laurus Labs Ltd.
- Lupin Ltd.
- Macleods Pharmaceuticals Ltd.
- MSN Laboratories
- NATCO Pharma Ltd.
- Nivagen Pharmaceuticals Inc.
- Strides Pharma Ltd.
- Teva Pharmaceutical Ltd.
- Viatris Inc.
- Zydus Group
